Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Trop Med Hyg ; 93(5): 1070-3, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26416117

ABSTRACT

To improve the knowledge base of Borrelia in north Africa, we tested 257 blood samples collected from febrile patients in Oran, Algeria, between January and December 2012 for Borrelia species using flagellin gene polymerase chain reaction sequencing. A sequence indicative of a new Borrelia sp. named Candidatus Borrelia algerica was detected in one blood sample. Further multispacer sequence typing indicated this Borrelia sp. had 97% similarity with Borrelia crocidurae, Borrelia duttonii, and Borrelia recurrentis. In silico comparison of Candidatus B. algerica spacer sequences with those of Borrelia hispanica and Borrelia garinii revealed 94% and 89% similarity, respectively. Candidatus B. algerica is a new relapsing fever Borrelia sp. detected in Oran. Further studies may help predict its epidemiological importance.


Subject(s)
Borrelia/isolation & purification , Relapsing Fever/epidemiology , Relapsing Fever/microbiology , Algeria/epidemiology , Base Sequence , Borrelia/classification , Borrelia/genetics , DNA Primers/genetics , DNA, Bacterial/blood , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Intergenic/chemistry , Flagellin/genetics , Geography , Humans , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Sequence Analysis, DNA
2.
Int J Infect Dis ; 28: 107-10, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25245003

ABSTRACT

OBJECTIVES: Q fever has been reported throughout the African continent. The objective of this study was to detect the presence of Coxiella burnetii in febrile patients from Africa. METHODS: Blood samples from febrile and non-febrile patients from six African countries and from France were investigated retrospectively for Q fever infection by molecular assays targeting the IS1111 and IS30A spacers. RESULTS: We tested 1888 febrile patients from Senegal, Mali, Tunisia, Algeria, Gabon, and Morocco and found one male adult patient (0.3%) infected with C. burnetii in Algeria and six positive patients (0.5%) in Senegal. For one patient from Senegal we determined that the infection was caused by C. burnetii genotype 35. In Senegal, more patients were infected with C. burnetii in Keur Momar Sarr (p=0.002) than in the other locations. Blood samples taken from 500 (51% males) non-febrile people from Senegal and France were all negative. CONCLUSIONS: The installation of point-of-care laboratories in rural Africa can be a very effective tool for studying the epidemiology of many infectious diseases.


Subject(s)
Coxiella burnetii/isolation & purification , Q Fever/microbiology , Adolescent , Adult , Africa/epidemiology , Algeria/epidemiology , Coxiella burnetii/genetics , Female , France , Genotype , Humans , Infant , Male , Morocco/epidemiology , Polymerase Chain Reaction , Q Fever/diagnosis , Q Fever/epidemiology , Rural Population , Senegal/epidemiology , Tunisia/epidemiology , Urban Population , Young Adult
3.
Emerg Infect Dis ; 19(11): 1775-83, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24188709

ABSTRACT

This study aimed to compare the epidemiology of Rickettsia felis infection and malaria in France, North Africa, and sub-Saharan Africa and to identify a common vector. Blood specimens from 3,122 febrile patients and from 500 nonfebrile persons were analyzed for R. felis and Plasmodium spp. We observed a significant linear trend (p<0.0001) of increasing risk for R. felis infection. The risks were lowest in France, Tunisia, and Algeria (1%), and highest in rural Senegal (15%). Co-infections with R. felis and Plasmodium spp. and occurrences of R. felis relapses or reinfections were identified. This study demonstrates a correlation between malaria and R. felis infection regarding geographic distribution, seasonality, asymptomatic infections, and a potential vector. R. felis infection should be suspected in these geographical areas where malaria is endemic. Doxycycline chemoprophylaxis against malaria in travelers to sub-Saharan Africa also protects against rickettsioses; thus, empirical treatment strategies for febrile illness for travelers and residents in sub-Saharan Africa may require reevaluation.


Subject(s)
Malaria/epidemiology , Rickettsia Infections/epidemiology , Adolescent , Adult , Africa/epidemiology , Africa South of the Sahara , Africa, Northern , Animals , Child , Child, Preschool , Disease Vectors , Female , France , Geography, Medical , Humans , Incidence , Infant , Malaria/transmission , Male , Middle Aged , Plasmodium/genetics , Prevalence , Rickettsia Infections/transmission , Rickettsia felis/genetics , Young Adult
4.
J Infect ; 66(1): 18-26, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23041039

ABSTRACT

Plague has caused ravaging outbreaks, including the Justinian plague and the "black death" in the Middle Ages. The causative agents of these outbreaks have been confirmed using modern molecular tests. The vector of plague during pandemics remains the subject of controversy. Nowadays, plague must be suspected in all areas where plague is endemic in rodents when patients present with adenitis or with pneumonia with a bloody expectorate. Diagnosis is more difficult in the situation of the reemergence of plague, as in Algeria for example, told by the first physician involved in that outbreak (NM). When in doubt, it is preferable to prescribe treatment with doxycycline while waiting for the test results because of the risk of fatality in individuals with plague. The typical bubo is a type of adenitis that is painful, red and nonfluctuating. The diagnosis is simple when microbiological analysis is conducted. Plague is a likely diagnosis when one sees gram-negative bacilli in lymph node aspirate or biopsy samples. Yersinia pestis grows very easily in blood cultures and is easy to identify by biochemical tests and MALDI-TOF mass spectrometry. Pneumonic plague and septicemic plague without adenitis are difficult to diagnose, and these diagnoses are often made by chance or retrospectively when cases are not part of an epidemic or related to another specific epidemiologic context. The treatment of plague must be based on gentamicin or doxycycline. Treatment with one of these antibiotics must be started as soon as plague is suspected. Analysis of past plague epidemics by using modern laboratory tools illustrated the value of epidemic buboes for the clinical diagnosis of plague; and brought new concepts regarding its transmission by human ectoparasites.


Subject(s)
Epidemics/history , Plague/history , Plague/microbiology , Yersinia pestis/isolation & purification , Adult , Animals , Anti-Bacterial Agents/therapeutic use , Communicable Diseases, Emerging/drug therapy , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/microbiology , History, 19th Century , History, 20th Century , History, 21st Century , History, Medieval , Humans , Infant , Male , Plague/drug therapy , Plague/epidemiology , Rats , Siphonaptera/microbiology , Yersinia pestis/growth & development
6.
Int J Infect Dis ; 13(2): 227-35, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18930677

ABSTRACT

INTRODUCTION: Mediterranean spotted fever (MSF) due to Rickettsia conorii is the most important tick-borne disease occurring in North Africa. However, there are only a few fragmentary reports on the epidemiology and clinical aspects of rickettsioses in North Africa, and cases are still rarely documented. We report herein a prospective study conducted in Oran, the second largest city in Algeria. This disease has not been properly described in Oran or in other Algerian cities. METHODS: A total of 167 cases of Mediterranean spotted fever were documented for the first time by the use of reference methods including immunofluorescence serology and Western blot and absorption studies, including isolation in culture by the shell-vial techniques, and molecular tools. RESULTS: Although some aspects of MSF were found to be in accordance with the general epidemiology of the disease, uncommon aspects were found, including increased incidence and the presence of multiple inoculation eschars in 12% of patients. The role of climatic changes in alterations of host-seeking and feeding behaviors of the vectors, including the brown dog tick Rhipicephalus sanguineus, is discussed. Also, 49% of patients were hospitalized with a severe form. The global death rate was 3.6%, but it was 54.5% in patients hospitalized with major neurological manifestations and multiorgan involvement. CONCLUSIONS: The present report gives a unique panel of clinical aspects of MSF as well as new trends in this disease. Entomological, climatic, and molecular studies are needed to better understand both epidemiological and clinical aspects of MSF.


Subject(s)
Boutonneuse Fever/epidemiology , Rickettsia conorii/pathogenicity , Adolescent , Adult , Aged , Aged, 80 and over , Algeria/epidemiology , Animals , Anti-Bacterial Agents/therapeutic use , Arachnid Vectors/growth & development , Arachnid Vectors/microbiology , Boutonneuse Fever/drug therapy , Boutonneuse Fever/microbiology , Boutonneuse Fever/physiopathology , Child , Child, Preschool , Doxycycline/therapeutic use , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Middle Aged , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/microbiology , Rhipicephalus sanguineus/growth & development , Rhipicephalus sanguineus/microbiology , Rickettsia conorii/isolation & purification , Young Adult
8.
Ann N Y Acad Sci ; 1078: 180-4, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17114705

ABSTRACT

The presumptive cases of Mediterranean spotted fever have been identified in 1993 and since that time, its frequency has steadily increased. The prospective study, in summer 2004, was conducted in order to present the descriptive clinic and epidemiology, to identify more severe forms, the presence of the multiple eschars, and different rickettsial strains caused the disease in our region. In Oran, the cases were diagnosed clinically. In Marseille, serum specimens were tested by IFA using the panel of eight rickettsial antigen; Western blot and cross-adsorption studies were also performed in order to confirm the diagnosis. Ninety-three patients clinically diagnosed were recorded from July 3 to October 28, 2004. Eighty percent were male, the mean age was 44.3 years, 90% were exposed to dog and 32% reported tick bites. Clinical signs were as follow: presence of underlying disease (44%), sudden onset (78%), fever (100%), loss of weight (63%), conjunctivitis (43%), and a tache noire was noticed in 70%. Interestingly, two patients had two and three eschars, respectively. The rash was maculopapular (palm and sole) and purpuric in nine cases. Doxycycline was the most antibiotic (91%) with favourable outcome in 91% of the cases. Malignant form with death is reported for three patients (3.2%). Among the 93 patients, 104 serum from 65 patients were tested (serums of others patients were lost or ticket not found on tube. Sixty-three patients out of 65 had a positive serology by IFA with cross-reactive antibodies especially between R. conorii, R. felis and/or R. typhi. Two others negative serology were: one precocious serum and second from the patient, which presented symptoms of MSF and tested two serums, Western blot and cross-adsorption.


Subject(s)
Rickettsia Infections/epidemiology , Algeria/epidemiology , Diagnosis, Differential , Fever/etiology , Humans , Incidence , Rickettsia Infections/blood , Rickettsia Infections/classification , Rickettsia Infections/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL